Raymond James Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.94M Sell
71,682
-26,651
-27% -$1.47M ﹤0.01% 2539
2025
Q1
$6.95M Buy
98,333
+16,519
+20% +$1.17M ﹤0.01% 2082
2024
Q4
$5.38M Buy
+81,814
New +$5.38M ﹤0.01% 2283